BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 20701601)

  • 21. New biological and genetic classification and therapeutically relevant categories in childhood B-cell precursor acute lymphoblastic leukemia.
    Starý J; Zuna J; Zaliova M
    F1000Res; 2018; 7():. PubMed ID: 30345005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A triple-probe FISH screening strategy for risk-stratified therapy of acute lymphoblastic leukaemia in low-resource settings.
    Parihar M; Singh MK; Islam R; Saha D; Mishra DK; Saha V; Krishnan S
    Pediatr Blood Cancer; 2018 Dec; 65(12):e27366. PubMed ID: 30168245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dynamic clonal progression in xenografts of acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21.
    Sinclair PB; Blair HH; Ryan SL; Buechler L; Cheng J; Clayton J; Hanna R; Hollern S; Hawking Z; Bashton M; Schwab CJ; Jones L; Russell LJ; Marr H; Carey P; Halsey C; Heidenreich O; Moorman AV; Harrison CJ
    Haematologica; 2018 Apr; 103(4):634-644. PubMed ID: 29449437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intrachromosomal amplification of chromosome 21 in Korean pediatric patients with B-cell precursor acute lymphoblastic leukemia in a single institution.
    Yang M; Yi ES; Kim HJ; Yoo KH; Koo HH; Kim SH
    Blood Res; 2017 Jun; 52(2):100-105. PubMed ID: 28698845
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Germ line mutations associated with leukemias.
    Porter CC
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):302-308. PubMed ID: 27913495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequency and Clinical Characteristics of Intrachromosomal Amplification of Chromosome 21 in Korean Childhood B-lineage Acute Lymphoblastic Leukemia.
    Kim J; Lyu CJ; Shin S; Lee ST; Choi JR
    Ann Lab Med; 2016 Sep; 36(5):475-80. PubMed ID: 27374714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New and emerging prognostic and predictive genetic biomarkers in B-cell precursor acute lymphoblastic leukemia.
    Moorman AV
    Haematologica; 2016 Apr; 101(4):407-16. PubMed ID: 27033238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emerging technologies in paediatric leukaemia.
    Dixon-McIver A
    Transl Pediatr; 2015 Apr; 4(2):116-24. PubMed ID: 26835367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytogenetic and Molecular Findings in Children with Acute Lymphoblastic Leukemia: Experience of a Single Institution in Argentina.
    Coccé MC; Alonso CN; Rossi JG; Bernasconi AR; Rampazzi MA; Felice MS; Rubio PL; Eandi Eberle S; Medina A; Gallego MS
    Mol Syndromol; 2015 Oct; 6(4):193-203. PubMed ID: 26648836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genomics and drug profiling of fatal TCF3-HLF-positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options.
    Fischer U; Forster M; Rinaldi A; Risch T; Sungalee S; Warnatz HJ; Bornhauser B; Gombert M; Kratsch C; Stütz AM; Sultan M; Tchinda J; Worth CL; Amstislavskiy V; Badarinarayan N; Baruchel A; Bartram T; Basso G; Canpolat C; Cario G; Cavé H; Dakaj D; Delorenzi M; Dobay MP; Eckert C; Ellinghaus E; Eugster S; Frismantas V; Ginzel S; Haas OA; Heidenreich O; Hemmrich-Stanisak G; Hezaveh K; Höll JI; Hornhardt S; Husemann P; Kachroo P; Kratz CP; Te Kronnie G; Marovca B; Niggli F; McHardy AC; Moorman AV; Panzer-Grümayer R; Petersen BS; Raeder B; Ralser M; Rosenstiel P; Schäfer D; Schrappe M; Schreiber S; Schütte M; Stade B; Thiele R; von der Weid N; Vora A; Zaliova M; Zhang L; Zichner T; Zimmermann M; Lehrach H; Borkhardt A; Bourquin JP; Franke A; Korbel JO; Stanulla M; Yaspo ML
    Nat Genet; 2015 Sep; 47(9):1020-1029. PubMed ID: 26214592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Childhood acute lymphoblastic leukemia: Integrating genomics into therapy.
    Tasian SK; Loh ML; Hunger SP
    Cancer; 2015 Oct; 121(20):3577-90. PubMed ID: 26194091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Home pesticide exposures and risk of childhood leukemia: Findings from the childhood leukemia international consortium.
    Bailey HD; Infante-Rivard C; Metayer C; Clavel J; Lightfoot T; Kaatsch P; Roman E; Magnani C; Spector LG; Th Petridou E; Milne E; Dockerty JD; Miligi L; Armstrong BK; Rudant J; Fritschi L; Simpson J; Zhang L; Rondelli R; Baka M; Orsi L; Moschovi M; Kang AY; Schüz J
    Int J Cancer; 2015 Dec; 137(11):2644-63. PubMed ID: 26061779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The pre-B-cell receptor checkpoint in acute lymphoblastic leukaemia.
    Eswaran J; Sinclair P; Heidenreich O; Irving J; Russell LJ; Hall A; Calado DP; Harrison CJ; Vormoor J
    Leukemia; 2015 Aug; 29(8):1623-31. PubMed ID: 25943180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ras pathway mutations are prevalent in relapsed childhood acute lymphoblastic leukemia and confer sensitivity to MEK inhibition.
    Irving J; Matheson E; Minto L; Blair H; Case M; Halsey C; Swidenbank I; Ponthan F; Kirschner-Schwabe R; Groeneveld-Krentz S; Hof J; Allan J; Harrison C; Vormoor J; von Stackelberg A; Eckert C
    Blood; 2014 Nov; 124(23):3420-30. PubMed ID: 25253770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evolutionary trajectories of hyperdiploid ALL in monozygotic twins.
    Bateman CM; Alpar D; Ford AM; Colman SM; Wren D; Morgan M; Kearney L; Greaves M
    Leukemia; 2015 Jan; 29(1):58-65. PubMed ID: 24897505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An international study of intrachromosomal amplification of chromosome 21 (iAMP21): cytogenetic characterization and outcome.
    Harrison CJ; Moorman AV; Schwab C; Carroll AJ; Raetz EA; Devidas M; Strehl S; Nebral K; Harbott J; Teigler-Schlegel A; Zimmerman M; Dastuge N; Baruchel A; Soulier J; Auclerc MF; Attarbaschi A; Mann G; Stark B; Cazzaniga G; Chilton L; Vandenberghe P; Forestier E; Haltrich I; Raimondi SC; Parihar M; Bourquin JP; Tchinda J; Haferlach C; Vora A; Hunger SP; Heerema NA; Haas OA;
    Leukemia; 2014 May; 28(5):1015-21. PubMed ID: 24166298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genes commonly deleted in childhood B-cell precursor acute lymphoblastic leukemia: association with cytogenetics and clinical features.
    Schwab CJ; Chilton L; Morrison H; Jones L; Al-Shehhi H; Erhorn A; Russell LJ; Moorman AV; Harrison CJ
    Haematologica; 2013 Jul; 98(7):1081-8. PubMed ID: 23508010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk-based classification of leukemia by cytogenetic and multiplex molecular methods: results from a multicenter validation study.
    Gocke CD; Mason J; Brusca L; Laosinchai-Wolf W; Higgs C; Newell H; Masters A; Friar L; Karp J; Griffiths M; Wei Q; Labourier E
    Blood Cancer J; 2012 Jul; 2(7):e78. PubMed ID: 22852047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic and clinical characterization of 45 acute leukemia patients with MLL gene rearrangements from a single institution.
    Cerveira N; Lisboa S; Correia C; Bizarro S; Santos J; Torres L; Vieira J; Barros-Silva JD; Pereira D; Moreira C; Meyer C; Oliva T; Moreira I; Martins Â; Viterbo L; Costa V; Marschalek R; Pinto A; Mariz JM; Teixeira MR
    Mol Oncol; 2012 Oct; 6(5):553-64. PubMed ID: 22846743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beyond the 2008 World Health Organization classification: the role of the hematopathology laboratory in the diagnosis and management of acute lymphoblastic leukemia.
    McGregor S; McNeer J; Gurbuxani S
    Semin Diagn Pathol; 2012 Feb; 29(1):2-11. PubMed ID: 22372201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.